Group One Trading’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-213
Closed -$12.2K – 7738
2023
Q2
$15.3K Sell
213
-225
-51% -$14.2K ﹤0.01% 6155
2023
Q1
$29.5K Buy
438
+437
+43,700% +$26.2K ﹤0.01% 5252
2022
Q4
$28 Sell
1
-82
-99% -$2.43K ﹤0.01% 7106
2022
Q3
$2K Hold
83
– – ﹤0.01% 7125
2022
Q2
$4K Buy
+83
New +$3.81K ﹤0.01% 7180
2021
Q4
– Sell
-83
Closed -$9.31K – 8300
2021
Q3
$13K Buy
+83
New +$13.5K ﹤0.01% 7376
2020
Q2
– Sell
-332
Closed -$61K – 5834
2020
Q1
$51K Buy
+332
New +$33.5K ﹤0.01% 3701
2019
Q4
– Sell
-20
Closed -$2K – 5178
2019
Q3
$2K Buy
20
+15
+300% +$1.74K ﹤0.01% 4906
2019
Q2
$1K Hold
5
– – ﹤0.01% 4808
2019
Q1
$1K Sell
5
-228
-98% -$35.5K ﹤0.01% 4654
2018
Q4
$38K Sell
233
-17
-7% -$3.38K ﹤0.01% 3685
2018
Q3
$64K Sell
250
-261
-51% -$65.4K ﹤0.01% 3825
2018
Q2
$117K Buy
+511
New +$96.8K ﹤0.01% 3443
2017
Q4
– Sell
-13
Closed -$1.65K – 4893
2017
Q3
$2K Sell
13
-210
-94% -$21.4K ﹤0.01% 4635
2017
Q2
$19K Sell
223
-95
-30% -$8.33K ﹤0.01% 3965
2017
Q1
$29K Buy
318
+250
+368% +$27.9K ﹤0.01% 3703
2016
Q4
$7K Buy
68
+5
+8% +$547 ﹤0.01% 4023
2016
Q3
$8K Buy
+63
New +$6.55K ﹤0.01% 4105

Other funds holding CTSO

Group One Trading's CTSO Position: Q3 2023 in Review

Group One Trading sold out of Cytosorbents Corp (CTSO) in Q3 2023, closing a stake of 213 shares — an estimated $12.2K sold.

Group One Trading first reported a position in CTSO in Q3 2016 and held it in 18 quarters. The position peaked at $117K in Q2 2018. 51 funds tracked by Wall St. Rank hold CTSO as of Q3 2023.

  • Group One Trading reported no remaining Cytosorbents Corp position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 213 Cytosorbents Corp shares in Q3 2023, an estimated $12.2K.
  • Group One Trading first reported a position in Cytosorbents Corp in Q3 2016 and held it in 18 quarters.
  • Group One Trading's Cytosorbents Corp position peaked at $117K in Q2 2018.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.